Efficacy and Safety of Vatelizumab in Patients with Relapsing Remitting Multiple Sclerosis

Update Il y a 4 ans
Reference: EUCTR2014-001643-20

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the efficacy of vatelizumab compared to placebo as measured by a reduction in new contrast-enhancing lesions (CELs) in RRMS patients To evaluate mutiple doses of vatelizumab for a dose-response.


Inclusion criteria

  • Nervous System Diseases